EP4 receptor as a novel promising therapeutic target in colon cancer
Vahid Karpisheh(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Mahdi Edalati(Tabriz University of Medical Sciences), Behzad Beyzai(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Navneet Joshi(Mody University of Science and Technology), Angelina Olegovna Zekiy(Sechenov University), Afshin Namdar(University of Alberta)
Cited by 54
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review
|Stem Cell Research & Therapy|2022|404
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
RETRACTED ARTICLE: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders
|Stem Cell Research & Therapy|2021|275
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222